1VQW
Crystal structure of a protein with similarity to flavin-containing monooxygenases and to mammalian dimethylalanine monooxygenases
Replaces: 1YBPSummary for 1VQW
Entry DOI | 10.2210/pdb1vqw/pdb |
Descriptor | PROTEIN WITH SIMILARITY TO FLAVIN-CONTAINING MONOOXYGENASES AND TO MAMMALIAN DIMETHYLALANINE MONOOXYGENASES, FLAVIN-ADENINE DINUCLEOTIDE, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, ... (4 entities in total) |
Functional Keywords | dimer, flavin-containing, nysgxrc, protein structure initiative, psi, t1729, structural genomics, new york sgx research center for structural genomics, unknown function |
Biological source | Schizosaccharomyces pombe (fission yeast) |
Total number of polymer chains | 2 |
Total formula weight | 104837.33 |
Authors | Eswaramoorthy, S.,Swaminathan, S.,Burley, S.K.,New York SGX Research Center for Structural Genomics (NYSGXRC) (deposition date: 2005-01-05, release date: 2005-01-11, Last modification date: 2024-10-30) |
Primary citation | Eswaramoorthy, S.,Bonanno, J.B.,Burley, S.K.,Swaminathan, S. Mechanism of action of a flavin-containing monooxygenase. Proc.Natl.Acad.Sci.Usa, 103:9832-9837, 2006 Cited by PubMed Abstract: Elimination of nonnutritional and insoluble compounds is a critical task for any living organism. Flavin-containing monooxygenases (FMOs) attach an oxygen atom to the insoluble nucleophilic compounds to increase solubility and thereby increase excretion. Here we analyze the functional mechanism of FMO from Schizosaccharomyces pombe using the crystal structures of the wild type and protein-cofactor and protein-substrate complexes. The structure of the wild-type FMO revealed that the prosthetic group FAD is an integral part of the protein. FMO needs NADPH as a cofactor in addition to the prosthetic group for its catalytic activity. Structures of the protein-cofactor and protein-substrate complexes provide insights into mechanism of action. We propose that FMOs exist in the cell as a complex with a reduced form of the prosthetic group and NADPH cofactor, readying them to act on substrates. The 4alpha-hydroperoxyflavin form of the prosthetic group represents a transient intermediate of the monooxygenation process. The oxygenated and reduced forms of the prosthetic group help stabilize interactions with cofactor and substrate alternately to permit continuous enzyme turnover. PubMed: 16777962DOI: 10.1073/pnas.0602398103 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report